Pediatric Hematology/Oncology

Multiple Myeloma

Questions discussed in this category

What are your top takeaways in Hematologic Malignancies from ASH 2024?

12 Answers available

Papers discussed in this category

Cancer, 2023 Jun 24

Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML.

The New England journal of medicine, 2024 Jun 03

Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.

Nature medicine, 2024 Jun 03

Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial.

Related Topics in Pediatric Hematology/Oncology